Malin to raise €330m via IPO

Malin, the Irish-backed investment firm targeting privately-owned life-science companies, has surpassed its initial funding hopes, by raising up to €330m in what is being viewed as one of Europe’s largest ever IPOs for the life sciences market.

The newly-formed company, backed by former Elan executives, last month announced its intention to raise between €275m and €325m via an IPO. Yesterday, the company – which has been formed out of south Dublin-based firm Brandon Point Industries, which is run by former Elan executive John Given – announced that it has successfully raised up to €330m via committed gross proceeds of €302m and up to €28m of additional investment commitments.

The company, which intends to invest in lifescience firms who see trade sales or IPOs as premature moves, will have just over 30.2 million new ordinary shares, at a price of €10 per share admitted to the Irish Stock Exchange’s secondary market, the ESM, next Wednesday.